Clinical trial
Role of Immunotherapy in the Treatment of Eyelid Viral Papilloma
NCT06720467 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Immunotherapy in the Treatment of Eyelid Viral Papilloma
- Lead sponsor
- Zagazig University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 11, 2024
- Completion date
- June 15, 2025
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.